157
Participants
Start Date
February 4, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
December 31, 2030
Collection of clinical data and biological sampling
Multiple measures relevant to cachexia, such as body weight, body mass index (BMI), muscle mass (handgrip strength using a Jamar hand dynamometer, mid-upper arm muscle circumference), appetite (Functional Assessment of Anorexia/Cachexia Therapy \[FAACT\], Simplified Nutritional Appetite Questionnaire \[SNAQ\], Automated Self- Administered Dietary Assessment Tool \[ASA24\]) will be recorded at inclusion (T0), after 6 months (T6) and after one year of follow-up (T12). Body composition will be assessed by bioelectrical impedance analysis at T0, T6 and T12, and by CT-scan at T0 and T12. In parallel, gut microbiota composition on feces collection will be determined at the two time points (T0 and T12). Markers of systemic and intestinal inflammation will be assessed at T0 and T12. Serum levels of uremic toxins will be measured at T0 and T12. Human muscle biopsies will be performed at the time of a surgical intervention.
RECRUITING
Cliniques universitaires Saint-Luc, Brussels
NOT_YET_RECRUITING
UCLouvain, Brussels
Fonds National de la Recherche Scientifique
OTHER
FRC- Fonds de la Recherche Clinique
UNKNOWN
SFNDT - Société Francophone de Néphrologie, Dialyse et Transplantation
UNKNOWN
Université Catholique de Louvain
OTHER